share_log

AstraZeneca | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

May 5, 2022 07:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more